Tingting Mou
Biographic Data
| ID | 7959768 |
|---|---|
| NAME | Tingting Mou |
| GIVEN NAMES | Tingting |
| FAMILY NAME | Mou |
| SIGNATURE | MOU T |
| AFFILIATIONS | Zhejiang University |
| ORCID | 0000-0002-8885-884X |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Increased plasma levels of IL-6 are associated with striatal structural atrophy in major depressive disorder patients with anhedonia
The present research outcomes suggest that anhedonia is associated with increased plasma levels of IL-6 and decreased GMV in the left striatal structures. In addition, this study demonstrates that GMV loss in the left putamen is related to increased plasma levels of IL-6 in MDD with anhedonia, which provides further insights into the possible mechanisms of anhedonia
Increased Hypocretin (Orexin) Plasma Level in Depression, Bipolar Disorder Patients
As hypocretin can markedly affect neurophysiological and behavioural processes in mood disorders. However, few studies have measured changes in hypocretin levels in patients with mood disorders. We estimated the hypocretin-1 plasma levels in mood disorder patients and controls (CON) using an enzyme-linked immunosorbent assay. Results: (i) The hypocretin-1 plasma level was significantly higher in major depressive disorder (MDD) patients [59.04 (35…
Gut Microbiota in Bipolar Depression and Its Relationship to Brain Function
The mechanism of bipolar disorder is unclear. Growing evidence indicates that gut microbiota plays a pivotal role in mental disorders. This study aimed to find out changes in the gut microbiota in bipolar depression (BD) subjects following treatment with quetiapine and evaluate their correlations with the brain and immune function. Totally 36 subjects with BD and 27 healthy controls (HCs) were recruited. The severity of depression was evaluated w…
No prominent works on this page.
Gut Microbiota in Bipolar Depression and Its Relationship to Brain Function
The mechanism of bipolar disorder is unclear. Growing evidence indicates that gut microbiota plays a pivotal role in mental disorders. This study aimed to find out changes in the gut microbiota in bipolar depression (BD) subjects following treatment with quetiapine and evaluate their correlations with the brain and immune function. Totally 36 subjects with BD and 27 healthy controls (HCs) were recruited. The severity of depression was evaluated w…
Increased Hypocretin (Orexin) Plasma Level in Depression, Bipolar Disorder Patients
As hypocretin can markedly affect neurophysiological and behavioural processes in mood disorders. However, few studies have measured changes in hypocretin levels in patients with mood disorders. We estimated the hypocretin-1 plasma levels in mood disorder patients and controls (CON) using an enzyme-linked immunosorbent assay. Results: (i) The hypocretin-1 plasma level was significantly higher in major depressive disorder (MDD) patients [59.04 (35…
Increased plasma levels of IL-6 are associated with striatal structural atrophy in major depressive disorder patients with anhedonia
The present research outcomes suggest that anhedonia is associated with increased plasma levels of IL-6 and decreased GMV in the left striatal structures. In addition, this study demonstrates that GMV loss in the left putamen is related to increased plasma levels of IL-6 in MDD with anhedonia, which provides further insights into the possible mechanisms of anhedonia
Internal Medicine (3 works) · Medicine (3 works) · Anxiety (2 works) · Bipolar disorder (2 works) · Depression (economics (2 works) · Major depressive disorder (2 works) · Psychiatry (2 works) · Psychology (2 works) · Tryptophan and brain disorders (2 works) · Anhedonia (1 works)